# Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
Canonical URL: https://biopharmsignal.com/news/PGNY/progyny-inc-announces-details-for-its-first-quarter-2026-results-report
Ticker: PGNY
Company: Progyny
Source: Progyny
Published: 2026-04-23 17:56 EST
Original Source URL: https://investors.progyny.com
## Summary

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended March 31, 2026, after the close of the market on Thursday, May 7, 2026.

## Article Body
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended March 31, 2026, after the close of the market on Thursday, May 7, 2026.
## Recent Company News
- 2026-05-28 13:04 EST — [New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System](https://biopharmsignal.com/news/PGNY/new-progyny-study-shows-growing-demand-for-human-guidance-in-an-increasingly-digital-healthcare-system) — Source: Progyny
- 2026-05-26 12:00 EST — [Progyny, Inc. Announces Share Repurchase Program](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-share-repurchase-program) — Source: Progyny
- 2026-05-11 14:57 EST — [Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference](https://biopharmsignal.com/news/PGNY/progyny-inc-to-present-at-bofa-securities-2026-health-care-conference) — Source: Progyny
- 2026-05-07 20:01 EST — [Progyny, Inc. Announces First Quarter 2026 Results](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-first-quarter-2026-results) — Source: Progyny
- 2026-04-23 17:56 EST — [Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-details-for-its-first-quarter-2026-results-report) — Source: Progyny
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)